Description
Seeking men and women with Chronic Myeloid Leukemia diagnosed within the last 3 months for a study of the effectiveness of an investigational drug compared to a Tyrosine Kinase Inhibitor (TKI) drug.
Overview
Participants in this study will either get the investigational drug or one of 4 different Tyrosine Kinase Inhibitor (TKI) drugs. Study visits are every 2 weeks for the first 3 months of the study and then every 3 months for up to 8 years.
What we're hoping for
We are studying whether and investigational drug is safe and effective for newly diagnosed Chronic Myeloid Leukemia compared to one of several Tyrosine Kinase Inhibitor (TKI) drugs.
Additional Information
ClinicalTrials.gov Identifier: NCT04971226